Non Hodgkin's and Hodgkin's lymphomas and HIV: frequency, outcome and immune response under HAART; Clermont-Ferrand University Hospital, 1991-2003;Lymphomes non hodgkiniens et hodgkiniens et infection VIH : fréquence, pronostic et reconstitution immune sous trithérapie antirétrovirale ; CHU de Clermont-Ferrand, 1991-2003

Medecine et Maladies Infectieuses

Volumn 36, Issue 3, 2006, Pages 157-162

  Jacomet, C ^a   Lesens, O ^a   Villemagne, B ^a   Darcha, C ^a   Tournilhac, O ^a   Henquell, C ^a   Cormerais, L ^a   Gourdon, F ^a   Peigue Lafeuille, H ^a   Travade, P ^a   Beytout, J ^a   Laurichesse, H ^a  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

Antiretroviral drugs; HIV infection; Hodgkin's disease; Immune restauration; Malignant non Hodgkin's lymphoma

Indexed keywords

CD4 ANTIGEN; ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CELL COUNT; CLINICAL ARTICLE; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNE STATUS; INCIDENCE; LIVER CARCINOMA; NONHODGKIN LYMPHOMA; OPPORTUNISTIC INFECTION; OUTCOME ASSESSMENT; REMISSION; SUICIDE; SURVIVAL RATE; UNIVARIATE ANALYSIS; UNIVERSITY HOSPITAL; ADULT; AIDS RELATED COMPLEX; B CELL LYMPHOMA; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; FEMALE; FRANCE; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; STATISTICS; SURVIVAL; TREATMENT OUTCOME;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; FRANCE; HIV INFECTIONS; HIV-1; HODGKIN DISEASE; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; LYMPHOMA, AIDS-RELATED; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33646159774     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2005.11.009     Document Type: Article

References (27)

1. Jones J.L., Hanson D.L., Dworkin M.S., Ward J.W., and Jaffe H.W. Effect of antiretroviral therapy on recent trends of selected cancers among HIV-infected persons. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 21 (1999) S11-S17
2. Matthews G.V., Bower M., Mandalia S., Powles T., Nelson M.R., and Gazzard B. Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active antiretroviral therapy. Blood 96 (2000) 2730-2734
3. Goedert J.J. The epidemiology of acquired immunodeficiency syndrome malignancies. Semin. Oncol. 27 (2000) 390-401
4. Vilchez R.A., Finch C.J., Jorgensen J.L., and Butel J.S. The clinical epidemiology of Hodgkin lymphoma in HIV-infected patients in the highly active antiretroviral therapy (HAART) era. Medicine 82 (2003) 77-81
5. Gerard L., Galicier L., Maillard A., Boulanger E., Quint L., Matheron S., et al. Systemic non lymphoma in HIV-infected patients with effective suppression of HIV replication: Persistent occurrence but improved survival. AIDS 30 (2002) 478-484
6. Gerard L., Galicier L., Boulanger E., Quint L., Lebrette M.G., Mortier A., et al. Improved survival in HIV-related Hodgkin's lymphoma since the introduction of highly active antiretroviral therapy. AIDS 17 (2003) 81-87
7. Thiessard F., Morlat P., Marinoutou C., Labouyrie E., Ragnaud J.M., Pellegrin J.L., et al. Pronostic factors after non_Hodgkin lymphoma in patients infected with the immunodeficiency virus. Aquitaine cohort, France 1986-1997. Groupe d'epidémiologie clinique du sida en Aquitaine (GESCA). Cancer 88 (2000) 1696-1702
8. Antinori A., Cingolani A., Alba L., Ammassari A., Serraino D., Ciancio, Palmieri F., et al. Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy. AIDS 15 (2001) 1483-1491
9. Besson C., Goubar A., Gabarre J., Rozenbaum W., Pialoux G., Chatelet A., et al. Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood 98 (2001) 2339-2344
10. Thirlwell C., Sarker D., Stebbing J., and Bower M. Acquired immunodeficiency syndrome-related lymphoma in the era of highly active antiretroviral therapy. Clin. Lymphoma 4 (2003) 86-92
11. Navarro J.T., Lloveras N., Ribera J.M., Oriol A., Mate J.L., and Feliu E. The prognosis of HIV-infected patients with diffuse large B-cell lymphoma treated with chemotherapy and highly active antiretroviral therapy is similar to that of HIV-negative patients receiving chemotherapy. Haematologica 90 (2005) 704-706
12. Engels E.A., Frisch M., Lubin J.H., Gail M.H., Biggar R.J., and Goedert J.J. Prevalence of hepatitis C virus infection and risk for hepatocellular carcinoma and non-Hodgkin lymphoma in AIDS. J. Aquir. Immune Defic. Syndrom 15 31 (2002) 536-541
13. Mele A., Pulsoni A., Bianco E., Musto P., Szklo A., Sanpaolo M.G., et al. Hepatitis C virus and B-cell non Hodgkin lymphomas: an Italian multicentrecase-control study. Blood 102 (2003) 996-999
14. Waters L., Stebbing J., Mandalia S., Young A.M., Nelson M., Gazzard, et al. Hepatitis C infection is not associated with systemic HIV-associated non Hodgkin's lymphoma: A cohort study. Int. J. Cancer. 116 (2005) 161-163
15. Besson C., and Raphael M. Lymphoma genesis in the context of HIV infection. Ann. Med. Interne (Paris) 154 (2003) 523-528
16. Oksenhendler E., Gerard L., Dubreuil M.L., Levy Y., Matheron S., Casals-Hatem D., et al. Intensive chemotherapy (LNHVIH-91 regimen) and G-CSF for HIV associated non-Hodgkin's lymphoma. Leuk. Lymphoma 39 (2000) 87-95
17. Hartmann P., Rehwald U., Salzberger B., Franzen C., and Diehl V. Current treatment strategies for patients with Hodgkin's lymphoma and HIV infection. Expert Rev. Anticancer Ther. 4 (2004) 401-410
18. Bonnet F., Lewden T., May L., Heripet E., Jougla E., Bonnet F., et al. Malignancy related causes of death in Human Immunodeficiency Virus-infected patients in the era of highly active antiretroviral therapy. Cancer 101 (2004) 317-324
19. Lim S.T., Karim R., Nathwni B.N., Tupule A., Espina B., and Levine A.M. AIDS-Related Burkitt's Lymphoma vs Diffuse Large Cell Lymphoma in the Pre-Highly Active Antiretroviral Therapy (HAART) and HAART Eras: Significant differences in survival with standard chemotherapy. Clin. Oncol. 23 (2005) 4430-4438
20. Klepfish A., Schatner A., Shvidel L., Shtalrid M., Haran M., Bentwich Z., et al. Successful treatment of aggressive HIV-associated non-Hodgkin's lymphoma with combination chemotherapy, biotherapy with rituximab and HAART: presentation of a therapeutic option. Leuk lymphoma 44 (2003) 349-351
21. Straus D.J. HIV-associated lymphoma: promising new results, but with toxicity. Blood 105 5 (2005) 1991-1997
22. Kaplan L.D., Lee J.Y., Ambinder R.F., Sparano J.A., Cesarman E., Chadburn A., et al. Rituximab does not improve clinical outcome in a randomized phase III trial of CHOP with or without rituximab in patients with HIV-associated non Hodgkin's lymphoma: AIDS-malignancies consortium trial 010. Blood 106 (2005) 1538-1543
23. Sabin C.A., Walker A.S., and Dunn D. HIV/HCV co-infection, HAART, and liver related mortality. Lancet 364 (2004) 757-758
24. Dockrell D.H., Poland G.A., Steckerlberg J.M., Wollan P.C., Strickland S.R., and Pomeroy C. Immunogenicity of three Haemophilus influenzae type b protein conjugate vaccines in HIV seropositive adults and analysis of predictors of vaccine response. Vaccine 17 (1999) 2779-2785
25. Picketty C., Castiel P., Belec L., Batisse D., Si Mohamed A., Gilquin J., et al. Discrepant responses to triple combination antiretroviral therapy in advanced HIV disease. AIDS 12 (1998) 745-750
26. Hirsch H.H., Kaufmann G., Sendi P., and Battegay M. Immune reconstitution in HIV-infected patients. Clin. Infect. Dis. 38 (2004) 1159-1166
27. Laporte R, Gerard Y, Ajana F, Yasdanpanah Y. Denis, G Baclet et al. Burkitt leukemia outcome following IL2 infusion in an HIV-infected patient. XV International AIDS Conference. Bangkok 2004. N° PeB5694.